Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Genmab A/S
CSE:GMAB
Genmab A/S
CSE:GMAB
Price:
2 263
DKK
-2.16%
Market Closed
Market Cap:
kr141.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genmab A/S
CSE:GMAB
|
DK |
|
T
|
Thermo Fisher Scientific Inc
BMV:TMO
|
US |
|
Bharat Heavy Electricals Ltd
BSE:500103
|
IN |
|
H
|
Hasbro Inc
SWB:HAS
|
US |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
C
|
Coles Group Ltd
SWB:2OF
|
AU |
|
C
|
Cairn Homes PLC
F:C5H
|
IE |
|
Foresta Group Holdings Ltd
ASX:FGH
|
AU |
|
M
|
Mint Incorporation Ltd
NASDAQ:MIMI
|
HK |
|
J
|
Japan Tobacco Inc
XMUN:JAT
|
JP |
|
S
|
Semen Indonesia (Persero) Tbk PT
XMUN:SMS2
|
ID |
|
F
|
freenet AG
XMUN:FNTN
|
DE |
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
US |
|
R
|
Ramelius Resources Ltd
XMUN:RRZ
|
AU |
Wall St Price Targets
GMAB Price Forecast
Based on 21 analysts
Based on 21 analysts
+13% Upside
from
kr2 263
today
Genmab A/S (GMAB)’s 12-month stock price forecast through October 2027 has a consensus target of kr2 550, implying 13% upside. The forecast is based on price targets from 21 Wall Street analysts.
GMAB Analyst Rating
No ratings yet
No ratings yet
Genmab A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GMAB's stock price target?
Price Target
2 550
DKK
2 550
DKK
According to Wall Street analysts, the average 1-year price target for GMAB is 2 550 DKK with a low forecast of 1 414 DKK and a high forecast of 4 200 DKK.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
20%
20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.